References
- InnesKESelfeTKAgarwalPRestless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic reviewSleep Med Rev201216430933921733722
- YehPWaltersASTsuangJWRestless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatmentSleep Breath2012164987100722038683
- InnesKESelfeTKAgarwalPPrevalence of restless legs syndrome in North American and Western European populations: a systematic reviewSleep Med201112762363421752711
- KushidaCAClinical presentation, diagnosis, and quality of life issues in restless legs syndromeAm J Med20071201 Suppl 1S4S1217198769
- NagandlaKDeSRestless legs syndrome: pathophysiology and modern managementPostgrad Med J201389105340241023524988
- ZintzarasEKitsiosGDPapathanasiouAARandomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysisClin Ther201032222123720206780
- WinkelmanJWConsidering the causes of RLSEur J Neurol200613Suppl 3S8S14
- SnyderAMConnorJRIron, the substantia nigra and related neurological disordersBiochim Biophys Acta20091790760661418778755
- AllenRPBarkerPBWehrlFSongHKEarleyCJMRI measurement of brain iron in patients with restless legs syndromeNeurology200156226326511160969
- WrzosekMLukaszkiewiczJWrzosekMVitamin D and the central nervous systemPharmacol Rep201365227127823744412
- ShinpoKKikuchiSSasakiHMoriwakaFTashiroKEffect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridineJ Neurosci Res200062337438211054806
- NakamuraKWangWKangUJThe role of glutathione in dopaminergic neuronal survivalJ Neurochem1997695185018589349527
- GómezACNavesDMRodríguezGMFernándezMJLCannataAJB[Review of the concept of vitamin D “sufficiency and insufficiency”]Nefrologia200323Suppl 2S73S77 Spanish
- AllenRPPicchiettiDHeningWATrenkwalderCWaltersASMontplaisiJRestless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of HealthSleep Med20034210111914592341
- SethiKDMehtaSHA clinical primer on restless legs syndrome: what we know, and what we don’t knowAm J Manag Care2012185 SupplS83S8823009275
- ConnorJRBoyerPJMenziesSLNeuropathological examination suggests impaired brain iron acquisition in restless legs syndromeNeurology200361330430912913188
- Rios RomenetsSPostumaRBTreatment of restless legs syndromeCurr Treat Options Neurol201315439640923703310
- RizzoGTononCMannersDTestaCLodiRImaging brain functional and metabolic changes in restless legs syndromeCurr Neurol Neurosci Rep201313937223881621
- MichaudMSoucyJPChabliALavigneGMontplaisirJSPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleepJ Neurol2002249216417011985381
- TurjanskiNLeesAJBrooksDJStriatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studiesNeurology199952593293710102408
- RuottinenHMPartinenMHublinCAn FDOPA PET study in patients with periodic limb movement disorder and restless legs syndromeNeurology200054250250410668725
- ConnorJRWangXSAllenRPAltered dopaminergic profile in the putamen and substantia nigra in restless leg syndromeBrain2009132Pt 92403241219467991
- EversSStögbauerFGenetic association of Huntington’s disease and restless legs syndrome? A family reportMov Disord200318222522712539222
- OndoWGLaiDAssociation between restless legs syndrome and essential tremorMov Disord200621451551816250022
- LespérancePDjerroudNDiazAARouleauGAChouinardSRicherFMontréal Tourette Study Group. Restless legs in Tourette syndromeMov Disord20041991084108715372602
- AllenRPEarleyCJThe role of iron in restless legs syndromeMov Disord200722Suppl 18S440S44817566122
- SunERChenCAHoGEarleyCJAllenRPIron and the restless legs syndromeSleep19982143713779646381
- O’KeeffeSTNoelJLavanJNRestless legs syndrome in the elderlyPostgrad Med J1993698157017038255834
- RizzoGMannersDTestaCLow brain iron content in idiopathic restless legs syndrome patients detected by phase imagingMov Disord201328131886189023780623
- LozoffBEarly iron deficiency has brain and behavior effects consistent with dopaminergic dysfunctionJ Nutr20111414740746
- JellenLCLuLWangXIron deficiency alters expression of dopamine-related genes in the ventral midbrain in miceNeuroscience2013252132323911809
- GarcionEWion-BarbotNMontero-MeneiCNBergerFWionDNew clues about vitamin D functions in the nervous systemTrends Endocrinol Metab200213310010511893522
- GarcionESindjiLLeblondelGBrachetPDarcyF1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl trans-peptidase and glutathione levels in rat primary astrocytesJ Neurochem199973285986610428085
- OrmeRPBhangalMSFrickerRACalcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expressionPLoS One201384e6204023626767
- BalabanHYildizÖKÇilGSerum 25-hydroxyvitamin D levels in restless legs syndrome patientsSleep Med201213795395722704399